TY  - GEN
AU  - Raal,Frederick J
AU  - Marais,A David
AU  - Klepack,Ellen
AU  - Lovalvo,Jennifer
AU  - McLain,Richard
AU  - Heinonen,Therese
TI  - Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia
SN  - 0021-9150
PY  - 2004///0826
KW  - Acetamides
KW  - Acetates
KW  - administration & dosage
KW  - Administration, Oral
KW  - Adolescent
KW  - Adult
KW  - Age Factors
KW  - Atorvastatin
KW  - Child
KW  - Cross-Over Studies
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Synergism
KW  - Drug Therapy, Combination
KW  - Enzyme Inhibitors
KW  - Female
KW  - Follow-Up Studies
KW  - Heptanoic Acids
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hyperlipoproteinemia Type II
KW  - diagnosis
KW  - Lipoproteins, HDL
KW  - drug effects
KW  - Lipoproteins, LDL
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Probability
KW  - Pyrroles
KW  - Reference Values
KW  - Risk Assessment
KW  - Severity of Illness Index
KW  - Sex Factors
KW  - Sterol O-Acyltransferase
KW  - antagonists & inhibitors
KW  - Sulfonamides
KW  - Sulfonic Acids
KW  - Treatment Outcome
KW  - Sterol O-Acyltransferase 2
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.atherosclerosis.2003.07.011
ER  -